Testing a Community Intervention to Increase Aspirin Use
NCT02607917 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10800
Last updated 2021-04-02
Summary
This research will test the effect of mass media or mass media plus a clinic based education program will improve appropriate aspirin use for cardiovascular disease prevention. It is a group randomized design of 24 geographic areas in Minnesota with adjacent states serving as controls.
Conditions
Interventions
- OTHER
-
Mass Media plus clinic intervention.
- OTHER
-
Media
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-02-16
- Primary Completion
- 2020-02-29
- Completion
- 2020-07-01
Countries
- United States
Study Locations
More Related Trials
-
Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
NCT00272311 ·Status: COMPLETED ·Phase: PHASE4
-
Personalizing Aspirin Therapy in Peripheral Arterial Disease Patients
NCT04269863 ·Status: UNKNOWN ·Phase: NA
-
Aspirin in Reducing Events in the Elderly
NCT01038583 ·Status: UNKNOWN
-
Laboratory Aspirin Resistance in Diabetics and Non-Diabetics
NCT00563875 ·Status: COMPLETED ·Phase: NA
-
Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease
NCT02370680 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin Withdrawal and Clinical Outcome in Patients With Moderate to High Cardiovascular Risk But Without Cardiovascular Disease
NCT03757156 ·Status: UNKNOWN ·Phase: NA
-
Effect of Aspirin on Gut Microbiome
NCT02761486 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome
NCT02520921 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Dose and Atherosclerosis in Patients With Heart Disease
NCT00272337 ·Status: COMPLETED ·Phase: PHASE4
-
ASPirin Intervention for the REDuction of Colorectal Cancer Risk
NCT02394769 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
NCT00501345 ·Status: TERMINATED ·Phase: PHASE3
-
Aspirin in Reduction of Tension II Study
NCT01379079 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial
NCT05932472 ·Status: RECRUITING ·Phase: PHASE4
-
Improving Aspirin Use Among Adults at Risk for Cardiovascular Disease (CVD)
NCT00981032 ·Status: COMPLETED ·Phase: NA
-
Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients
NCT01198379 ·Status: WITHDRAWN ·Phase: PHASE4
-
Aspirin Effectiveness Study
NCT01113060 ·Status: UNKNOWN
-
An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants
NCT03341390 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin Twice Daily in Diabetic Patients With Coronary Artery Disease
NCT01617031 ·Status: COMPLETED
-
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
NCT05347069 ·Status: RECRUITING ·Phase: PHASE4
-
Warfarin and Antiplatelet Vascular Evaluation
NCT00125671 ·Status: UNKNOWN ·Phase: PHASE3
-
Mechanism Based Resistance to Aspirin
NCT00948987 ·Status: COMPLETED ·Phase: PHASE1
-
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II
NCT05702463 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease
NCT00501059 ·Status: COMPLETED ·Phase: PHASE3
-
Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People
NCT00793754 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
NCT02697916 ·Status: COMPLETED ·Phase: NA